Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function
Alice Santi,Emily J Kay,Lisa J Neilson,Lynn McGarry,Sergio Lilla,Margaret Mullin,Nikki R Paul,Frédéric Fercoq,Grigorios Koulouras,Giovanny Rodriguez Blanco,Dimitris Athineos,Susan Mason,Mark Hughes,Gemma Thomson,Yann Kieffer,Colin Nixon,Karen Blyth,Fatima Mechta-Grigoriou,Leo M Carlin,Sara Zanivan,Emily J. Kay,Lisa J. Neilson,Nikki R. Paul,Leo M. Carlin
DOI: https://doi.org/10.1126/scisignal.ade0580
IF: 9.517
2024-03-13
Science Signaling
Abstract:Intercellular communication between different cell types in solid tumors contributes to tumor growth and metastatic dissemination. The secretome of cancer-associated fibroblasts (CAFs) plays major roles in these processes. Using human mammary CAFs, we showed that CAFs with a myofibroblast phenotype released extracellular vesicles that transferred proteins to endothelial cells (ECs) that affected their interaction with immune cells. Mass spectrometry–based proteomics identified proteins transferred from CAFs to ECs, which included plasma membrane receptors. Using THY1 as an example of a transferred plasma membrane–bound protein, we showed that CAF-derived proteins increased the adhesion of a monocyte cell line to ECs. CAFs produced high amounts of matrix-bound EVs, which were the primary vehicles of protein transfer. Hence, our work paves the way for future studies that investigate how CAF-derived matrix-bound EVs influence tumor pathology by regulating the function of neighboring cancer, stromal, and immune cells.
cell biology,biochemistry & molecular biology